# The Evaluation Studies of Curative Effect of Fu-zheng-qu-zhuo Oral Liquid in Treatment of Ischemic Nephropathy

> **NCT02044835** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Atherosclerotic Renal Artery Stenosis

## Interventions

- **DRUG:** Fu-zheng-qu-zhuo oral liquid

## Key facts

- **NCT ID:** NCT02044835
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-09
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044835, "The Evaluation Studies of Curative Effect of Fu-zheng-qu-zhuo Oral Liquid in Treatment of Ischemic Nephropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02044835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*